Amanda Chen named 2021 Forbes 30 Under 30
Tuesday, December 1, 2020
Chen designs and studies "microlivers," which could enable next-generation cell therapies that could help, or perhaps replace, organ transplants for end-stage diseases.
Chen designs and studies "microlivers," which could enable next-generation cell therapies that could help, or perhaps replace, organ transplants for end-stage diseases.